Eligibility Module

Eligibility Module

The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.

Eligibility Module path is as follows:

Study -> Protocol Section -> Eligibility Module

Eligibility Module


Ignite Creation Date: 2025-12-24 @ 7:43 PM
Ignite Modification Date: 2025-12-24 @ 7:43 PM
NCT ID: NCT03286803
Eligibility Criteria: Inclusion Criteria: * Children aged 14 weeks for arms A and B and 9 months for arms C and D living in four peri-urban slums of Bin Qasim Town, Karachi (Rehri Goth, Bhains Colony, Ali Akber Shah, Ibrahim Hydri) who have not received IPV vaccine during routine immunization for arms A and B and who have documentary evidence of receiving IPV vaccine at 14 weeks of age for arms C and D. Exclusion Criteria: * Child found acutely ill at the time of enrolment and requiring emergent medical care/hospitalization * Parents planning to shift out of the four communities during the study time (at least 18 months for arms A and B, and 1 year for arms C and D) * Refusal of blood testing * Already enrolled in any other clinical trial
Healthy Volunteers: True
Sex: ALL
Minimum Age: 14 Weeks
Maximum Age: 10 Months
Study: NCT03286803
Study Brief:
Protocol Section: NCT03286803